Belimumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
BENLYSTA belimumab 120 mg powder for injection vial AUST R: 173077Active ingredients:
Belimumab
Dosage form:
Injection, powder for
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
From
20 Mar 2025
to
04 Apr 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
An alternative strength is available.
|